Showing results (171-180 of 220) with videos related to
Sort By:
Pageof 22
East African Medical Journal|September 1, 1989
Preliminary trial of minidose heparin prophylaxis for painful sickle cell crisesH Chaplin, M C Monroe, A C Malecek, et al.Journal of Medicinal Chemistry|April 17, 1998
Potent antagonists of somatostatin: synthesis and biologyS J Hocart, R Jain, W A Murphy, et al.Endocrine Research|January 1, 1984
Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal menD Gonzalez-Barcena, F Mendoza, R Medina, et al.Proceedings of the National Academy of Sciences of the United States of America|January 1, 1980
[Phe4]somatostatin: a potent, selective inhibitor of growth hormone releaseC A Meyers, D H Coy, W A Murphy, et al.Medicine|November 1, 1989
X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adultsI R Reid, D C Hardy, W A Murphy, et al.Peptides|August 22, 2001
Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the ratH C Champion, R L Pierce, T J Bivalacqua, et al.The American Journal of Medicine|January 1, 1991
X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometryI R Reid, W A Murphy, D C Hardy, et al.The American Journal of Physiology|December 1, 1992
Analysis of systemic and pulmonary vascular responses to PACAP and VIP: role of adrenal catecholaminesR K Minkes, T J McMahon, T R Higuera, et al.Life Sciences|January 1, 1997
Proadrenomedullin NH2-terminal peptide (PAMP)(12-20) has vasodepressor activity in the rat and catR C Fry, H C Champion, T C Lawrence, et al.Peptides|January 1, 1997
Adrenomedullin (16-31) has pressor activity in the rat but not the catH C Champion, D E Friedman, D G Lambert, et al.Pageof 22